Cargando…
Therapeutic Vaccine Strategies against Human Papillomavirus
High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by viral oncoproteins. These are essential for the induction and maintenance of the malignant phenotype. Thus, HPV-mediated ma...
Autores principales: | Khallouf, Hadeel, Grabowska, Agnieszka K., Riemer, Angelika B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494257/ https://www.ncbi.nlm.nih.gov/pubmed/26344626 http://dx.doi.org/10.3390/vaccines2020422 |
Ejemplares similares
-
The Invisible Enemy – How Human Papillomaviruses Avoid Recognition and Clearance by the Host Immune System
por: Grabowska, Agnieszka K, et al.
Publicado: (2012) -
Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
por: Nayereh, Khadem Ghaebi, et al.
Publicado: (2012) -
Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009) -
Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007) -
Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)